Prognostic value of microRNAs in heart failure

Yang, Jie; Yang, Xuesong; Fan, Shaowei; Zhao, Xiaoyu; Li, Chao; Zhao, Zheng-Yao; Pei, Hui-Juan; Lü, Qin; Zhuang, Xin; Yang, Chuan-Hua

doi:10.1097/md.0000000000027744

Cited by 17 publications

(19 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 110 patients with A. baumannii bacteremia were included in this study, including 61 patients in the survival group and 49 patients in the nonsurvival group. The case fatality rate on 28 days was 44.55%, which was similar to the results reported by Huang et al (2020) and Yang et al (2021). In this study, we found that the detection of A. baumannii was mainly concentrated in the ICU.…”

Section: Discussionsupporting

confidence: 91%

“…Vincent et al (1996) conducted the first retrospective analysis of SOFA score in the first 24 h of 1,643 infected patients, and the results showed that SOFA score was well correlated with mortality. Although SOFA alone has been considered a predictor of mortality in previous studies, the limitation of SOFA is that it does not take into account the patient's age and previous medical history, so there are limitations in the assessment (Yang et al, 2021). For critically ill patients, APACHE II score is recommended to predict the severity of the disease, and the higher the APACHE II score, the more severe the disease (Rhodes et al, 2017).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Microbiological characteristics and risk factors on prognosis associated with Acinetobacter baumannii bacteremia in general hospital: A single-center retrospective study

Wei

Zhou²,

Zhang³

et al. 2022

Front. Microbiol.

View full text Add to dashboard Cite

ObjectiveAcinetobacter baumannii is one of the most important pathogenic bacteria causing nosocomial infections and has a high mortality rate. Assessment of the microbiological characteristics and risk factors on prognosis associated with A.baumannii is essential. In this study, we aimed to investigate the clinical characteristics and prognostic risk factors of patients with A.baumannii bacteremia.Patients and MethodsThis study retrospectively analyzed the antibiotic resistance of pathogens based on the clinical data of A.baumannii bacteremia patients presented in a tertiary teaching hospital from 2017 to 2022. Logistic regression and decision tree identified the prognostic risk factors for patients with baumannemia. Kaplan-Meier method was used for survival analysis between MDR and Non-MDR groups. The area under receiver-operating characteristic curve (ROC curve) was used to compare the predictive value of the APACHE II score and Sequential Organ Failure Assessment (SOFA) score.ResultsA total of 110 patients with positive A. Baumannii blood cultures were included. Most of the patients were from intensive care unit (ICU) wards. The drug sensitivity results showed that the resistance rate of A. baumannii to colistin was the lowest (1.1%), followed by tigecycline (3.6%).The survival time of MDR group was significantly shorter than that of Non-MDR group. Multivariate analysis showed that, APACHE II score and SOFA score were independent risk factors affecting the prognosis of 28 days of A.baumannii bacteremia. And both scores displayed excellent AUROCs (SOFA: 0.909, APACHE II: 0.895 in predicting 28-day mortality). The two scoring systems were highly correlated and predicted no significant difference (r2 = 0.4410, P < 0.001). We found that SOFA > 7 and APACHE II > 21 are associated with significantly higher mortality rates.ConclusionA.baumannii bacteremia have the highest incidence in the ICU, with high drug resistance and mortality rates. The survival time of patients with MDR A. Baumannii bacteremia was significantly shortened. The SOFA score and APACHE II score can reflect the severity of A.baumannii bacteremia patients and evaluate the 28-day prognosis. In addition, for the convenience of calculation, the SOFA score may be more clinically useful than the APACHE II score in predicting the mortality rate of A.baumannii bacteremia.

show abstract

Section: Discussionsupporting

confidence: 91%

Section: Discussionmentioning

confidence: 99%

Microbiological characteristics and risk factors on prognosis associated with Acinetobacter baumannii bacteremia in general hospital: A single-center retrospective study

Wei

Zhou²,

Zhang³

et al. 2022

Front. Microbiol.

View full text Add to dashboard Cite

show abstract

“…Latest meta analysis assessed the prognostic utility of 19 circulating miRNAs included in four relevant articles in heart failure patients. Meta analysis showed that patients with low expression of miR-16-5p and miR-27a levels have significantly worse overall survival [ 87 ]. MiR-27a was found significantly lower in patients with atherosclerosis compared to healthy individuals, however the study included only 25 patients and 26 controls [ 88 ].…”

Section: Discussionmentioning

confidence: 99%

Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19

et al. 2022

View full text Add to dashboard Cite

SARS-CoV-2 tropism for the ACE2 receptor, along with the multifaceted inflammatory reaction, is likely to drive the generalized hypercoagulable and thrombotic state seen in patients with COVID-19. Using the original bioinformatic workflow and network medicine approaches we reanalysed four coronavirus-related expression datasets and performed co-expression analysis focused on thrombosis and ACE2 related genes. We identified microRNAs (miRNAs) which play role in ACE2-related thrombosis in coronavirus infection and further, we validated the expressions of precisely selected miRNAs-related to thrombosis (miR-16-5p, miR-27a-3p, let-7b-5p and miR-155-5p) in 79 hospitalized COVID-19 patients and 32 healthy volunteers by qRT-PCR. Consequently, we aimed to unravel whether bioinformatic prioritization could guide selection of miRNAs with a potential of diagnostic and prognostic biomarkers associated with disease severity in patients hospitalized for COVID-19. In bioinformatic analysis, we identified EGFR, HSP90AA1, APP, TP53, PTEN, UBC, FN1, ELAVL1 and CALM1 as regulatory genes which could play a pivotal role in COVID-19 related thrombosis. We also found miR-16-5p, miR-27a-3p, let-7b-5p and miR-155-5p as regulators in the coagulation and thrombosis process. In silico predictions were further confirmed in patients hospitalized for COVID-19. The expression levels of miR-16-5p and let-7b in COVID-19 patients were lower at baseline, 7-days and 21-day after admission compared to the healthy controls (p < 0.0001 for all time points for both miRNAs). The expression levels of miR-27a-3p and miR-155-5p in COVID-19 patients were higher at day 21 compared to the healthy controls (p = 0.007 and p < 0.001, respectively). A low baseline miR-16-5p expression presents predictive utility in assessment of the hospital length of stay or death in follow-up as a composite endpoint (AUC:0.810, 95% CI, 0.71–0.91, p < 0.0001) and low baseline expression of miR-16-5p and diabetes mellitus are independent predictors of increased length of stay or death according to a multivariate analysis (OR: 9.417; 95% CI, 2.647–33.506; p = 0.0005 and OR: 6.257; 95% CI, 1.049–37.316; p = 0.044, respectively). This study enabled us to better characterize changes in gene expression and signalling pathways related to hypercoagulable and thrombotic conditions in COVID-19. In this study we identified and validated miRNAs which could serve as novel, thrombosis-related predictive biomarkers of the COVID-19 complications, and can be used for early stratification of patients and prediction of severity of infection development in an individual. Abbreviations: ACE2, angiotensin-converting enzyme 2AF, atrial fibrillationAPP, Amyloid Beta Precursor ProteinaPTT, activated partial thromboplastin timeAUC, Area under the curveAβ, amyloid betaBMI, body mass indexCAD, coronary artery diseaseCALM1, Calmodulin 1 geneCaM, calmodulinCCND1, Cyclin D1CI, confidence intervalCOPD, chronic obstructive pulmonary diseaseC...

show abstract

“…The downregulation of hsa-miR-423-3p has been previously reported as a biomarker for acute ischemic stroke patients ( 30 ) and has been associated with worse overall survival in patients with heart failure ( 59 ). However, its upregulation has been linked with onset and severity of Type 1 diabetes ( 60 , 61 ) and it also showed high predictive potential in identifying T2DM remission after sleeve gastrectomy ( 62 ).…”

Section: Discussionmentioning

confidence: 99%

Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus

Toor

Al-Dous²,

Parray³

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Stroke is the second leading cause of global mortality and continued efforts aim to identify predictive, diagnostic, or prognostic biomarkers to reduce the disease burden. Circulating microRNAs (miRNAs) have emerged as potential biomarkers in stroke. We performed comprehensive circulating miRNA profiling of ischemic stroke patients with or without type 2 diabetes mellitus (T2DM), an important risk factor associated with worse clinical outcomes in stroke. Serum samples were collected within 24 h of acute stroke diagnosis and circulating miRNAs profiled using RNA-Seq were compared between stroke patients with T2DM (SWDM; n = 92) and those without T2DM (SWoDM; n = 98). Our analysis workflow involved random allocation of study cohorts into discovery (n = 96) and validation (n = 94) datasets. Five miRNAs were found to be differentially regulated in SWDM compared to SWoDM patients. Hsa-miR-361-3p and -664a-5p were downregulated, whereas miR-423-3p, -140-5p, and -17-3p were upregulated. We also explored the gene targets of these miRNAs and investigated the downstream pathways associated with them to decipher the potential pathways impacted in stroke with diabetes as comorbidity. Overall, our novel findings provide important insights into the differentially regulated miRNAs, their associated pathways and potential utilization for clinical benefits in ischemic stroke patients with diabetes.

show abstract

Prognostic value of microRNAs in heart failure

Cited by 17 publications

References 44 publications

Microbiological characteristics and risk factors on prognosis associated with Acinetobacter baumannii bacteremia in general hospital: A single-center retrospective study

Microbiological characteristics and risk factors on prognosis associated with Acinetobacter baumannii bacteremia in general hospital: A single-center retrospective study

Thrombosis-related circulating miR-16-5p is associated with disease severity in patients hospitalised for COVID-19

Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus

Contact Info

Product

Resources

About